Skip to content

Clinical trials

Colonic Neoplasms trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colonic Neoplasms Country / region: Singapore Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20101
20111
20131
20161
20174
20202
20212
20222
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting5
Recruiting3
Unknown status2
Approved for marketing1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Novartis Pharmaceuticals3
Amgen1
Apollomics Inc.1
Changi General Hospital1
Hoffmann-La Roche1
Merck Sharp & Dohme LLC1
Mirati Therapeutics Inc.1
NantCell, Inc.1
National Cancer Centre, Singapore1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colonic Neoplasms19
Colorectal Neoplasms10
Rectal Neoplasms9
Carcinoma, Non-Small-Cell Lung8
Lung Neoplasms7
Neoplasms6
Intestinal Neoplasms5
Thyroid Neoplasms5
Adenocarcinoma4
Breast Neoplasms4

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.